Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

199
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
199
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

29
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Development of Human Microbiota01:30

Development of Human Microbiota

61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

7.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.2K
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

96
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mannosylated hemagglutinin peptides bind cyanovirin-N independent of disulfide-bonds in complementary binding sites.

RSC advances·2022
Same author

Particle Radiation Side-Effects: Intestinal Microbiota Composition Shapes Interferon-γ-Induced Osteo-Immunogenicity.

Radiation research·2022
Same author

Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability.

Molecules (Basel, Switzerland)·2021
Same author

Intestinal bacterial indicator phylotypes associate with impaired DNA double-stranded break sensors but augmented skeletal bone micro-structure.

Carcinogenesis·2019
Same author

A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period.

Gut microbes·2018
Same author

Retraction Note to: Mouse models of intestinal inflammation and cancer.

Archives of toxicology·2018

Related Experiment Video

Updated: Apr 29, 2026

Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes
08:14

Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes

Published on: May 8, 2016

27.5K

Intestinal microbiome and lymphoma development.

Mitsuko L Yamamoto1, Robert H Schiestl

  • 1From the Department of Pathology, Environmental Health, Radiation Oncology, UCLA Schools of Medicine and Public Health, Los Angeles, CA.

Cancer Journal (Sudbury, Mass.)
|May 24, 2014
PubMed
Summary

Animal models reveal how gut microbiota interactions can cause mucosal-associated lymphoid tissue lymphoma. Further research into this gut-immune axis may improve lymphoma treatment.

More Related Videos

Isolating Lymphocytes from the Mouse Small Intestinal Immune System
11:28

Isolating Lymphocytes from the Mouse Small Intestinal Immune System

Published on: February 28, 2018

54.7K
Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
11:06

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques

Published on: May 2, 2017

54.7K

Related Experiment Videos

Last Updated: Apr 29, 2026

Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes
08:14

Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes

Published on: May 8, 2016

27.5K
Isolating Lymphocytes from the Mouse Small Intestinal Immune System
11:28

Isolating Lymphocytes from the Mouse Small Intestinal Immune System

Published on: February 28, 2018

54.7K
Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
11:06

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques

Published on: May 2, 2017

54.7K

Area of Science:

  • Microbiology
  • Immunology
  • Oncology

Background:

  • The gut immune system and intestinal microbiota must coexist, balancing tolerance and activation.
  • The gut microbiota comprises trillions of microbes, some essential for human health.
  • Dysbiosis and specific bacteria are linked to lymphomas, like mucosal-associated lymphoid tissue (MALT) lymphoma.

Purpose of the Study:

  • To review the application of animal models in understanding microbiota-induced lymphoma.
  • To elucidate the mechanisms by which gut microbes contribute to lymphoma development.
  • To highlight the potential of targeting the microbiota-gut axis for lymphoma therapy.

Main Methods:

  • Review of studies utilizing animal models to investigate gut microbiota and lymphoma.
  • Analysis of mechanisms linking specific bacteria to MALT lymphoma.
  • Examination of host-microbe interactions in the gut immune system.

Main Results:

  • Animal models have been crucial in establishing bacterial causation and mechanisms of MALT lymphoma.
  • Evidence suggests a significant interplay between gut microbiota composition and lymphoma development.
  • Specific bacterial species have been identified as potential triggers for MALT lymphoma.

Conclusions:

  • The gut microbiota plays a demonstrable role in the pathogenesis of certain lymphomas.
  • Animal models provide valuable insights into microbiota-driven lymphoma.
  • Targeting the gut microbiota holds promise for future lymphoma treatment strategies.